AlTi Global, Inc.
For the period ended Dec 31, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
ALTI$2.47+5.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 3.
| For the Year Ended | |||
|---|---|---|---|
| (Dollars in Thousands) | December 31, 2024 | December 31, 2023 | December 31, 2022 (Predecessor) |
| Cash Flows from Operating Activities | |||
| Net income (loss) | $(174,305) | $(311,215) | $(5,998) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 14,552 | 17,039 | 2,339 |
| Amortization of debt discounts and deferred financing costs | 6,184 | 927 | — |
| Unrealized (gain) loss on investments | 16,483 | 15,618 | 97 |
| Realized (gain) loss on investments | (11,128) | — | — |
| Impairment loss on goodwill and intangible assets | 116,769 | 206,777 | — |
| Fair value (gain) loss on TRA | (3,855) | 233 | — |
| Gain (loss) on earn-in | — | — | 221 |
| (Income) loss on equity method investments | 1,898 | 3,019 | (33) |
| Restricted unit compensation | — | — | 2,365 |
| Fair value (gain) loss on warrant liability | — | 12,866 | — |
| Fair value (gain) loss on earnout liability | (30,727) | (31,104) | — |
| Fair value gain (loss) on preferred stock tranche liability | (600) | — | — |
| Deferred income tax (benefit) expense | (24,055) | (12,387) | (101) |
| Equity-settled share-based payments | 17,454 | 36,749 | — |
| Unrealized foreign currency (gains)/losses | 14 | 587 | — |
| (Gain) loss from retirement of debt | — | (73) | — |
| Forgiveness of debt shareholder loan | — | — | 619 |
| Forgiveness of debt of notes receivable from members | 212 | 261 | 263 |
| Fair value of interest rate swap | — | 33 | (276) |
| Cash flows due to changes in operating assets and liabilities | |||
| (Increase) decrease in fees receivable | 38,229 | (31,321) | 1,336 |
| (Increase) decrease in other assets | (20,579) | (5,860) | (2,993) |
| Operating cash flow from operating leases | 5,736 | 7,147 | 618 |
| Increase (decrease) in accounts payable and accrued expenses | (1,214) | (17,897) | 2,279 |
| Increase (decrease) in accrued compensation and profit sharing | (15,761) | 36,345 | 2,460 |
| Increase (decrease) in other liabilities | 14,057 | (9,202) | 3,662 |
| Other operating activities | (16) | (248) | — |
| Net cash provided by (used in) operating activities | (50,652) | (81,706) | 6,858 |
| (Continued on the following page) | |||
| (Continued from the previous page) | For the Year Ended | ||
|---|---|---|---|
| (Dollars in Thousands) | December 31, 2024 | December 31, 2023 | December 31, 2022 (Predecessor) |
| Cash Flows from Investing Activities | |||
| Cash acquired from consolidation of variable interest entity | — | — | 471 |
| Cash payment for acquisition of TWMH and TIG historical equity | — | (99,999) | — |
| Receipt of payments of notes receivable from members | 286 | 226 | 428 |
| Loans to members | — | — | (301) |
| Cash receipts from the repayment of advances and loans | — | 601 | — |
| Purchases of investments | (20,380) | (15,687) | (224) |
| Distributions from investments | — | — | 4 |
| Purchase of TIH shares | — | — | (382) |
| Purchase of Holbein | — | — | (8,097) |
| Cash payment for delayed share purchase agreement | (1,818) | — | — |
| Payment of payout right | — | (760) | — |
| Acquisition of AWMS, net of cash acquired | — | (4,383) | — |
| Acquisition of ALWP, net of cash acquired | — | (14,430) | — |
| Acquisition of EEA, net of cash acquired | (69,182) | — | — |
| Acquisition of PW, net of cash acquired | (1,467) | — | — |
| Acquisition of Envoi | (25,258) | — | — |
| Sales of investments | 818 | 2,107 | 1,028 |
| Proceeds from sale of FOS | 16,683 | — | — |
| Proceeds from sale of LXi REIT Advisors | 32,202 | — | — |
| Sale of fixed assets | 144 | 8 | — |
| Purchases of fixed assets | (7,713) | (630) | (156) |
| Net cash provided by (used in) investing activities | (75,685) | (132,947) | (7,229) |
| Cash Flows from Financing Activities | |||
| Proceeds from issuance of preferred stock and Allianz & Constellation Warrants | 300,800 | — | — |
| Proceeds from issuance of common stock | 94,660 | — | — |
| Proceeds from issuance of preferred stock tranche right liability | 4,540 | — | — |
| Member contribution (distribution) | (6,760) | (8,492) | (9,835) |
| Payments on term notes and lines of credit | (221,062) | (160,453) | (2,810) |
| Borrowings on term notes and lines of credit | 32,258 | 223,500 | 12,300 |
| Payment of acquisition-related contingent consideration | (8,449) | — | — |
| Payments of debt issuance costs | (1,519) | (2,586) | — |
| Taxes paid on net settled share-based compensation awards | (4,037) | — | — |
| Tax payments on behalf of Umbrella partners | (424) | — | — |
| Increase (decrease) in distributions due to former TIG members | — | (14,199) | — |
| Cash payment for purchase of shares to be transferred as part of Alvarium share compensation | — | (4,215) | — |
| Cash receipts from exercise of Warrants | — | 5,836 | — |
| Payment of preferred stock and Allianz & Constellation Warrants issuance costs | (10,544) | — | — |
| Payment of common stock issuance costs | (4,236) | — | — |
| Payment of preferred stock tranche right liability issuance costs | (203) | — | — |
| Cash payment of earn-in liability | (754) | — | — |
| Dividends paid to former owners of AWMS and ALWP | (11) | (3,372) | — |
| Net cash provided by (used in) financing activities | 174,259 | 36,019 | (345) |
| Effect of exchange rate changes on cash | (673) | 2,793 | (193) |
| Net increase (decrease) in cash | 47,249 | (175,841) | (909) |
| Cash and cash equivalents at beginning of the period | 18,245 | 194,086 | 8,040 |
| Cash and cash equivalents at end of the period | $65,494 | $18,245 | $7,131 |
| (Continued on the following page) | |||
| (Continued from the previous page) | For the Year Ended | ||
|---|---|---|---|
| (Dollars in Thousands) | December 31, 2024 | December 31, 2023 | December 31, 2022 (Predecessor) |
| Reconciliation of balance sheet cash and cash equivalents to cash flows: | |||
| Cash and cash equivalents on balance sheet | $65,494 | $15,348 | $7,131 |
| Cash and cash equivalents included in Assets held for sale (Note 3) | — | 2,897 | — |
| Cash and cash equivalents, including cash in Assets held for sale | $65,494 | $18,245 | $7,131 |
| Supplemental Disclosure of Cash Flow Information | |||
| Cash Paid During the Period for: | |||
| Income taxes | $1,474 | $848 | $606 |
| Interest payments on term notes and lines of credit | $16,712 | $14,079 | $622 |
| Supplemental disclosure of noncash investing activities: | |||
| Non-cash delayed share purchase agreement | $— | $— | $1,818 |
| Supplemental disclosure of noncash financing activities: | |||
| Non-cash repayment of notes receivable in lieu of cash member distribution | $— | $— | $202 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.